SML3901
Crenolanib trifluoroacetate
≥98% (HPLC)
别名:
1-[2-[5-[(3-Methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine trifluoroacetate, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine trifluoroacetate, ARO 00 trifluoroacetate2, CP 868596 trifluoroacetate, CP868596 trifluoroacetate
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C26H29N5O2 · xC2HF3O2
分子量:
443.54 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.21
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated
Quality Segment
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
N6(CCC(CC6)N)c1c2nc(ccc2ccc1)[n]3c4c(nc3)cc(cc4)OCC5(COC5)C
InChI
1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
InChI key
DYNHJHQFHQTFTP-UHFFFAOYSA-N
Biochem/physiol Actions
Crenolanib is an orally bioavailable, potent and selective platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitor. Also crenolanib potently inhibits FLT3.
Platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitor
Disclaimer
Hygroscopic
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable